logo

Biodistribution study of [61Cu]pyruvaldehyde-bis (N-4-methylthiosemicarbazone) in normal rats as a PET tracer

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE

Biodistribution study of [61Cu]pyruvaldehyde-bis (N-4-methylthiosemicarbazone) in normal rats as a PET tracer

Amir Reza JALILIAN
Saeed SHANESAZZADEH
Pejaman ROWSHANFARZAD
Fatemeh BOLOURINOVIN
Abbas MAJDABADI
Nuclear Science and TechniquesVol.19, No.3pp.159-164Published in print 20 Jun 2008
49700

[61Cu]-labeled pyruvaldehyde-bis(N-4-methylthiosemicarbazone) (61Cu-PTSM), a promising agent made for imaging blood perfusion, was produced via the natZn(p,x)61Cu nuclear reaction in a 30 MeV cyclotron, and separated by a two-step column chromatography method developed in our laboratory using a cation and an anion exchange resin. After 150 μA irradiation for 76 min, about 6.006 Ci of 61Cu2+ was obtained with a radiochemical separation yield of 95% and a radionuclidic purity of 99%. 61Cu-PTSM was prepared using an optimized method with in-house synthesized PTSM ligand for radiolabeling following quality control procedures using RTLC and HPLC. The tracer is mostly incorporated in heart, kidneys and brain compared to free copper cation as a control. These are in agreement with former reports. In conclusion, [61Cu]-PTSM was prepared at the radiopharmaceutical scales with high quality and is a potential PET tracer in the perfusion study of the heart, kidney, brain and tumors.

Copper-61PTSMBiodistributionRadiolabeling
References
[1] Jalilian AR, Seyfi P, Afarideh H, et al. Int. J Appl Radiat Isot. 2000, 5: 545-555.
[2] Jalilian AR, Afarideh H, Shafiee A, et al. J Pharm Pharmaceut. Sci. 2000; 23: 114-124.
[3] Jalilian AR, Afarideh H, Shafiee A, et al. J Labelled Compd Radiopharm. 2001, 44: 11-21.
[4] Tolmachev V, Lundqvist H, Einarsson L. Int J Appl Radiat Isot. 1998, 49: 79-81.
[5] McCarthy DW, Bass LA, Cutler PD, et al. Nucl Med Biol. 1999, 26: 351-358.
[6] Ma DF, Lu T, et al. Nucl Med Biol. 2002; 29: 91-105
[7] Fukumura T, Okada K, Szelecsényi F, et al. Radiochimica Acta. 2004, 92: 209-214.
[8] Lewis JS, Sharp TL, Laforest R, et al. J Nucl Med. 2001, 42: 655-661.
[9] Rowshanfarzad P, Sabet M, Jalilian AR, et al. Applied Radiation and Isotopes, 2006, 64:1563-1573.
[10] Jalilian AR, Sabet M, Rowshanfarzad P, et al. Journal of Radioanalytical and Nuclear Chemistry, 2006, 269: 147-154.
[11] Jalilian AR, Rowshanfarzad P, Sabet M. Nukleonika, 2006, 51: 111-117.
[12] Jalilian AR, Rowshanfarzad P, Sabet M, et al. Applied Radiation and Isotopes, 2006, 64: 337-341.
[13] Green MA. Nucl Med Biol 1987, 14:59-61.
[14] Marczenko Z. Spectrophotometric determination of elements, 4th Ed. Warsaw:Ellis Horwood Ltd., 1976:601-603.
[15] Kostyniak PJ, Nakeeb SM, Schopp EM, et al. J Appl Toxicol, 1990, 10:417-421.
[16] Shelton ME, Green MA, Mathias CJ, et al. Circulation, 1990, 82:990-997.
[17] Young H, Carnochan P, Zweit J, et al. Eur J Nucl Med, 1994, 21:336-341.
[18] Young H, Carnochan P, Zweit J, et al. J Nucl Biol Med, 1994, 38:89-91.
[19] Wada K, Fujibayashi Y, Taniuchi H, et al. Nucl Med Biol, 1994, 21:613-617.
[20] Jason SL, Laforest R, Buettner TL, et al. Proc Natl Acad Sci USA, 2001, 98:1206-1211.
[21] Blann M, Bislinghoff J,

Code Alice/Livermore 91, Lawrence Livermore National Laboratory, Internal Report, UCID-19614

(1991).
Baidu ScholarGoogle Scholar
[22] Ziegler JF, Biersack JP, Littmark U. The stopping and range of ions in matter (SRIM Code). Version 2000 XX, 2000.
[23] Weisberg A M, Gold plating, 9th Ed., ASM International, U.S.A, 1990:247.
[24] Hilgers K, Stoll T, Skakun Y, et al. Appl Radiat Isot, 2003, 59:343-351.
[25] Boothe TE, Tavano E, Munoz J, et al. J Label Comp Radiopharm, 1991, 30:108.
[26] Gingras BA, Suprunchuk T, Bayley CH. Can J Chem, 1962, 40:1053-1057.
[27] Marczenko Z. Spectrophotometric determination of elements, 4th Ed., Chichester: Ellis Horwood Ltd., 1976:369.
[28] Wallhaus TR, Lacy J, Whang J, et al. J Nucl Med, 1998, 39:1958-1964.